11/13/2024
3:16 PM | Structure Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
9:34 AM | FMR LLC (Filed by)
Structure Therapeutics (Subject)
| Form SC 13G/A | |
11/08/2024
9:52 AM | Structure Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
09/20/2024
4:41 PM | Coll Crespo Blas (Reporting)
Structure Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/20/2024
4:42 PM | Coll Crespo Blas (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
4:45 PM | Hall Ashley (Reporting)
Structure Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/20/2024
4:47 PM | Hall Ashley (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/28/2024
3:35 PM | Russell Angus C. (Reporting)
Structure Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/28/2024
3:37 PM | Russell Angus C. (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
3:16 PM | Structure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
3:23 PM | Structure Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/27/2024
4:00 PM | Structure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
3:15 PM | Structure Therapeutics (Issuer)
WELCH DANIEL G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:15 PM | Structure Therapeutics (Issuer)
TETLOW SHARON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:15 PM | DOBMEIER ERIC (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:15 PM | Structure Therapeutics (Issuer)
Waldstreicher Joanne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:15 PM | LOVE TED W (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
7:19 PM | Stevens Raymond C (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
8:07 AM | FMR LLC (Reporting)
Structure Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/12/2024
3:42 PM | Stevens Raymond C (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
4:07 PM | Stevens Raymond C (Reporting)
Structure Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024
11:15 PM | Structure Therapeutics (Filer)
| Form EFFECT | |
06/05/2024
6:38 PM | Lin Xichen (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
6:43 PM | Structure Therapeutics (Filer)
| Form S-1MEF | |
06/03/2024
7:00 AM | Structure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2024
5:57 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Structure Therapeutics (Subject)
| Form SC 13G | |
05/09/2024
3:56 PM | Structure Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
3:10 PM | Structure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
4:24 PM | Structure Therapeutics (Filer)
| Form ARS | |
04/19/2024
1:13 PM | FMR LLC (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
6:34 PM | Stevens Raymond C (Reporting)
Structure Therapeutics (Issuer)
| Form 4/A | |
03/20/2024
6:37 PM | Structure Therapeutics (Issuer)
Yoon Jun (Reporting)
| Form 4/A | |
03/20/2024
6:39 PM | Ma Yingli (Reporting)
Structure Therapeutics (Issuer)
| Form 4/A | |
03/20/2024
6:41 PM | Bach Mark Allen (Reporting)
Structure Therapeutics (Issuer)
| Form 4/A | |
03/20/2024
6:42 PM | Lin Xichen (Reporting)
Structure Therapeutics (Issuer)
| Form 4/A | |
03/19/2024
3:36 PM | Stevens Raymond C (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
7:52 AM | FMR LLC (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
3:19 PM | Structure Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/08/2024
8:19 AM | Structure Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/08/2024
7:43 AM | Structure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
10:11 AM | FMR LLC (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
This company will win the AI race (Ad) Rome wasn’t built in a day…
But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence.
And without it, the entire AI industry would collapse.  You must read this new presentation from Porter Stansberry. |
02/14/2024
8:07 AM | Avoro Capital Advisors LLC (Filed by)
Structure Therapeutics (Subject)
| Form SC 13G | |
02/14/2024
7:45 AM | Deep Track Capital, LP (Filed by)
Structure Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
8:49 AM | FMR LLC (Filed by)
Structure Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
6:59 AM | FIL Ltd (Filed by)
Structure Therapeutics (Subject)
| Form SC 13G/A | |
02/06/2024
10:01 AM | Structure Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
12/27/2023
9:49 AM | Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
9:49 AM | FMR LLC (Reporting)
FMR LLC (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:36 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Structure Therapeutics (Subject)
| Form SC 13G/A | |
12/18/2023
7:28 AM | Structure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/07/2023
10:04 AM | FMR LLC (Reporting)
Structure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2023
11:15 PM | Structure Therapeutics (Filer)
| Form EFFECT | |
11/17/2023
4:25 PM | Structure Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
11/17/2023
3:51 PM | Structure Therapeutics (Filer)
| Form 10-Q/A | |
11/17/2023
3:55 PM | Structure Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/16/2023
4:13 PM | Structure Therapeutics (Filer)
| Form 10-Q/A | |
